Table 4.
Classification accuracy of our method with other methods from literature (under 10-fold cross validation).
| (Authors, year) | Method | Leukemia | Colon | ||
|---|---|---|---|---|---|
| Acc (%) | S. G. | Acc (%) | S. G. | ||
| (Ruiz et al., 2006) [24] | NB-FCBF | 95.9 | 48.5 | 77.6 | 14.6 |
| (Shen et al., 2007) [8] | PSOSVM | N. C. | N. C. | 91.67 | 4.00 |
| (Li et al., 2008) [15] | Single PSO | 94.6 | 22.3 | 87.1 | 19.8 |
| (Li et al., 2008) [15] | Single GA | 94.6 | 23.1 | 87.1 | 17.5 |
| (Li et al., 2008) [17] | Hybrid PSO/GA | 97.2 | 18.7 | 91.90 | 18.00 |
| (Shen et al., 2008) [13] | HPSOTS | 98.61 | 7.00 | 93.32 | 8.00 |
| (Abdi et al., 2012) [18] | mRMR-PSO-WSVM | 98.74 | 4.1 | 93.55 | 6.8 |
∗S. G. and N. C. denote selected genes and not considered, respectively.